Bristol-Myers Squibb (BMY) Misses Q2 EPS by 23c, Lowers Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $54.70 +1.30%
Revenue Growth %: -4.6%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.6%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.75, $0.23 worse than the analyst estimate of $1.98. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $11.81 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2023 EPS of $7.35-$7.65, versus the consensus of $7.99.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- NVE Corporation names new CEO and expands board to seven members
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
